Declaration of medical writing assistance in international peer-reviewed publications [9]

JAMA

Volumn 296, Issue 8, 2006, Pages 932-934

  Woolley, Karen L ^a   Ely, Julie A ^b   Woolley, Mark J ^a   Findlay, Leigh ^a   Lynch, Felicity A ^a   Choi, Yoonah ^b   McDonald, Jane M ^c  

^a ProScribe Medical Communications   (Australia)

^b ProScribe Medical Communications   (Australia)

^c ProScribe Medical Communications   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONFIDENCE INTERVAL; DRUG INDUSTRY; EVIDENCE BASED MEDICINE; HEALTH CARE ORGANIZATION; HEALTH SURVEY; LETTER; LOGISTIC REGRESSION ANALYSIS; MEDICAL EDUCATION; MEDICAL ETHICS; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL PRACTICE; MEDICAL RESEARCH; MEDICAL SERVICE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; WRITING; ARTICLE; INTERNATIONAL COOPERATION; PEER REVIEW; PUBLISHING;

EDITORIAL POLICIES; INTERNATIONALITY; PEER REVIEW, RESEARCH; WRITING;

EID: 33747601432     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.296.8.932-b     Document Type: Letter

References (11)

1. Camacho LH, Bacik J, Cheung A, Spriggs DR. Presentation and subsequent publication rates of phase I oncology clinical trials. Cancer. 2005;104:1497-1504.
2. Wise P, Drury M. Pharmaceutical trials in general practice: the first 100 protocols: an audit by the clinical research ethics committee of the Royal College of General Practitioners. BMJ. 1996;313:1245-1248.
3. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: writing and editing for biomedical publication: ethical considerations in the conduct and reporting of research. http://www.icmje.org/index.html#ethic. Accessed November 1, 2005.
4. Wager E, Field EA, Grossman L. Good publication practice for pharmaceutical companies. Curr Med Res Opin. 2003;19:149-154.
5. Jacobs A, Wager E. European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications. Curr Med Res Opin. 2005;21:317-322.
6. Hamilton CW, Royer MG; AMWA 2002 Task Force on the Contributions of Medical Writers to Scientific Publications. AMWA position statement on the contributions of medical writers to scientific publications. AMWA Journal. 2003;18:13-16.
7. Flanagin A, Carey LA, Fontanarosa PB, et al. Prevalence of articles with honorary authors and ghost authors in peer-reviewed medical journals. JAMA. 1998;280:222-224.
8. Phillips SG, Carey LA, Biedermann G. Attitudes toward writing and writing assistance in peer-reviewed articles. AMWA Journal. 2001;16:10-16.
9. Healy DT. Transparency and trust: figure for ghost written articles was misquoted [letter]. BMJ. 2004;329:1345.
10. Koreith K. Medical writing market appreciation. The Centerwatch Monthly. 2004;11:104. http://www.centerwatch.com/careers/CW1107_medicalwriting.pdf. Accessed May 9, 2006.
11. Hamilton CW, Mallia-Hughes M, Mitrany D, Foote MA. Comments on "The corporate author" [letter]. J Gen Intern Med. 2005;20:972.